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ABSTRACT 
Objective: This research work was carried out to identify a potent microorganism, which produced the fibrinolytic enzyme and to optimise the 
media and growth parameters to achieve the maximal enzyme production for commercial application. 
Methods: Microorganisms were isolated from different sources and assayed for fibrinolytic activity. The shortlisted cultures after preliminary 
screening (casein hydrolysis, blood plate assay and blood clot dissolution) were identified using 16S rRNA amplification method. The media and 
growth parameters were optimized to achieve the maximal enzyme activity. In-silico studies were carried out to identify the activators and 
inhibitors of the enzyme. 
Results: Two species of Bacillus, namely, Bacillus amyloliquefaciens and Bacillus licheniformis, isolated from spoilt milk and soy flour, respectively, 
exhibited fibrinolytic activity. In the laboratory scale studies, of these two cultures, B. amyloliquefaciens produced the Fibrinolytic enzyme in higher 
quantities, 28.98 FU/mL, compared to 26.63 FU/mL in B. licheniformis. The maximal activities were obtained after 72 h. The optimum conditions at 
laboratory scale for the maximal production of the fibrinolytic enzyme were: pH 7.2, temperature 37 C and agitation 200 rpm. When scale up studies 
with B. amyloliquefaciens in a 7 L Fermentor were undertaken. The maximal activity obtained was 55.60 FU/mL in 72 h, compared to that of 28.98 
FU/mL in shake flask studies. The molecular weight of the enzyme was estimated to be about 38 kDa. In in-silico studies, it was observed that PMSF 
inhibited the fibrinolytic activity, thereby, confirming this fibrinolytic enzyme is a serine protease (Nattokinase).  
Conclusion: The enzyme had exhibited excellent blood clot dissolving property and therefore may be considered for further scale up and 
commercial exploitation. 
Keywords: Fibrinolytic enzyme, Bacillus sp, Optimisation, Scale up studies, Commercial prospects. 
 
INTRODUCTION 
Medical science has synthesised various compounds to help thin 
blood (from Aspirin to Warfarin and urokinase to streptokinase) and 
each has their own role. The use of blood thinners, either drugs or 
natural compounds, such as, garlic, ginseng, bromelain etc, may 
provide temporary relief by increasing the blood flow through 
blocked areas. However, this is only a quick-fix approach. To really 
address fibrin accumulation at its root, blood thinning is not enough. 
These blockages must be dissolved/removed and optimally 
prevented. Injectable drugs, such as, urokinase, streptokinase, 
Activase etc are used for this purpose in emergency situations [1]. 
While these medications certainly do the job, they are extremely 
expensive and short acting (4 – 20 min). Thus, fibrinolytic enzymes 
from microbial sources, like, Nattokinase, offer great promise in the 
management (7 – 8 h) and support of healthy blood circulation.  
It was Sumi et al [2], who first isolated and identified Nattokinase, a 
potent fibrinolytic enzyme, derived from Bacillus subtilis var natto 
from traditional Japanese soybean food, Natto. It is considered as a 
potent cardiovascular drug. Nattokinase is one of the most powerful 
new dietary supplements introduced in the market in recent years. 
This fibrinolytic enzyme (Nattokinase) is unique in profoundly 
lowering fibrinogen levels and degrading branched fibrin [3]. It has 
3 different mechanisms of action. It lyses fibrin directly, changes 
prourokinase to urokinase and increase tissue plasminogen 
activator, which increases our own plasmin. Nattokinase lessens 
excessive coagulation and thus improves circulation, increasing 
oxygen flow to tissues. Nattokinase is actually superior to 
conventional clot dissolving drugs [4] with many benefits, including 
oral administration, known efficacy, and the prolonged effects, cost 
effectiveness and prevention of clot formation. Nattokinase has been 
demonstrated to have pH and temperature stability and so can be 
found in the gastrointestinal tract [5]. Nattokinase belongs to the 
alkaline serine protease family, the catalytic centre which contains 
three conserved residues asp32, his64, and ser221 [6,7]. 
Nattokinase not only dissolves blood clots [8] but also degrades 
amyloid fibrils [9]. The major objective of this research work was (a) 
to identify a potent microorganism, which produced the fibrinolytic 
enzyme, comparable to Nattokinase (b) to optimise the media and 
growth parameters in order to achieve the maximal enzyme 
production and (c) to study its potential for commercial application.  
MATERIALS AND METHODS  
Bacteria and fungi, isolated from the samples of Soya flour, Soil from 
an abattoir in Chennai, spoilt milk, Rinds of Water Melon, Soybean 
and Shouyu (a Japanese soybean sauce) were subjected to Casein 
Hydrolysis Plate Assay method [10]. Twelve bacterial cultures, 
which exhibited clear zone in the plates (proteolytic activity), were 
further evaluated for their proteolytic enzyme producing capacity. 
The bacterial cultures were grown in a minimal medium prescribed 
by Deepak et al [11], but slightly modified, containing: Glucose 1.0%, 
Peptone 3.0%, MgSO4 0.20% and CaCl2
Two bacterial cultures, which were shortlisted based on the above 
screening procedures were identified using microscopic and 
biochemical tests [12]. The genomic DNA was isolated and 
quantified [13] and identification of the cultures was done by 
amplification of 16S rRNA analysis. Amplification for gene, specific 
for serine protease from B. amyloliquefaciens, was carried out in a 
gradient PCR unit [14]. 
 0.50%, pH adjusted to 7.0, at 
37 C at 200 rpm. After 72 h of growth, the biomass was separated by 
centrifugation (10,000 rpm, 15 min, 4 C) and the clear supernatant 
was taken for proteolytic enzyme assay as prescribed by Sigma-
Aldrich. The cultures were also grown on blood plates to observe the 
clear zone. Later, the crude enzyme (culture filtrate) preparations 
were tested for their property in dissolving the blood clot.  
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For the optimal production of proteolytic enzyme, various media, 
viz, glucose medium, yeast extract medium, glucose and soybean 
meal medium, maltose and wheat bran medium and green gram dhal 
(our own recipe) were tried. Effect of different carbon (glucose, 
fructose, xylose, sucrose, maltose and corn starch) and nitrogen 
(ammonium nitrate, ammonium sulphate, potassium nitrate, 
peptone, soybean meal and casein) sources were studied. The 
culture filtrates were periodically assayed for proteolytic activity 
(Sigma-Aldrich) and total protein content [15]. Experiments were 
also carried out to study the optimum pH (4.0 to 9.0), temperature 
(20 to 50 C) of the medium and the agitation (150 to 225 rpm). 
Based on the above studies, a production medium containing (%): 
Wheat bran 4.0, maltose 2.5, NH4NO3 0.3, Sodium chloride 0.5, 
KH2PO4 0.1, K2HPO4
Ammonium sulphate precipitation (20 – 80%) was tried for the 
partial purification of the enzyme. Dialysis was done until the 
protein concentrate was obtained. The ammonium sulphate fraction 
was further purified through Gel filtration using Sephadex G-75 gel 
(GE Health Care Life Science). SDS-PAGE electrophoresis was carried 
out with the protein concentrates [17].  
 0.4 and Magnesium sulphate 0.05 (pH 7.2), 
was optimized. The optimum pH for the enzyme activity was studied by 
varying the pH levels, ie, from 4.0 to 9.0. Similarly, the optimum 
temperature for the enzyme activity was estimated by studying the 
enzyme activity at different temperatures, from 20 - 50 C. The Fibrin 
Assay Method was carried out according to the protocol of Yin et al [16]. 
Scale up studies were carried out in a laboratory 7 L Fermentor 
(Scigenics. India). The composition of the seed medium (%) was: 
Glucose 2.0, Peptone 1.0, yeast extracts 0.6 at pH 7.2. The Production 
Medium (%) contained: Wheat bran 4.0, maltose 2.5, NH4NO3 0.3, 
Sodium chloride 0.5, KH2PO4 0.1, K2HPO4
As crystal structure of serine protease is unavailable, 3D structure 
was built using the homology modeling. The protein sequence of 
Nattokinase (Accession No: WP_017417394.1, length: 382 amino 
acid) was retrieved from NCBI GenBank. The template protein was 
identified using BLASTp tool. The crystallographic structure of 1SBN 
was downloaded from Protein Data Bank (PDB) and used as a 
template (resolution 2.10A). The possible binding pockets for the 
target protein were searched using Computed Atlas of Surface 
Topography of Proteins (CASTP) [7]. The binding pockets residues 
were then compared with active site residues of the template 
protein. The drug ligands was retrieved from NCBI-PubChem 
compound database [3,18] for molecular docking studies. The 
ligands were Serpin, Lupeol, PMSF, α-amyrin, ß-amyrin, Curcumin, 
IPTG, Serpin_Zn
 0.4, magnesium sulphate 
0.05 at pH 7.2. The culture filtrate was harvested after 72 h, filtered 
through a cloth filter and centrifuged (Beckman, 10,000 rpm, 15 
min). The clear supernatant was concentrated through 
ultrafiltration (Millipore, 10 KDa cartridge membrane). The 
concentrated enzyme was then made into powder (sodium chloride 
and Dextrin were used as fillers) by Spray drying (Labultima). The 
test enzyme was compared with other fibrinolytic enzymes using 
the blood clot dissolution method (time of dissolution). 
2+, Lupeol_Zn2+, α-amyrin_Zn2+, ß-amyrin_Zn2+, 
Curcumin_Zn2+
RESULTS AND DISCUSSION 
 and dipicolinic acid were selected [19,20]. 
Pharmacodynamics and Pharmacokinetics properties were 
determined for retrieved ligands using Qikprop tool of Schrodinger 
suite. In order to acquire a thorough understanding of binding 
affinity of each activator and inhibitor with modeled serine protease 
protein, a molecular docking study of retrieved ligands with 
modeled serine protease was performed employing Glide 
application of Schrodinger suite [21]. To gain further detailed 
knowledge of the modeled protein and ligand complex interaction 
and stability a molecular dynamics simulation of the complex 
obtained from docking was performed using Schrodinger suite. 
Forty five bacterial and thirty fungal cultures were isolated from the 
above mentioned sources. From these cultures, twelve 
microorganisms were shortlisted based on the clear zone in Casein 
Plates (Casein hydrolysis). They were grown in a minimal medium 
and the proteolytic enzyme activity was estimated in the culture 
filtrate. The results are presented in Table 1. It is clear from the 
results that two bacterial isolates, namely, MB and SF2, gave 
maximal protease activities. Incidentally, these two bacterial isolates 
exhibited bigger clear zones in the Casein plate assay. Both the 
cultures exhibited very clear zones in the blood plate assay and 
dissolved the blood clots. 
 
Table 1: Protease enzyme activity 
S. No. Culture Enzyme Activity (U/mL) 
1 SF1 1.45 
2 SF2 5.76 
3 SF3 1.24 
4 MB 6.70 
5 MB1 2.41 
6 MB2 1.36 
7 SB1 2.19 
8 SB2 3.21 
9 SH1 4.01 
10 SH2 2.90 
11 WM1 1.45 
12 WM2 3.67 
 
The final shortlisted two bacterial cultures were identified as gram 
positive rods. The bacterial cells were arranged in pairs or chains 
with single elliptical endospore, typical of Bacillus species [22]. 
Based on the results obtained from the biochemical tests, the 
cultures were confirmed as Bacillus species. 
Bac 16s-F: 5’ AGAGTTGATCATGGCTCAG 3’ 
The genomic DNA 
isolated from both the cultures was amplified and 16S rRNA was 
sequenced. The sequence of the primers used were:  
Bac 16s-R: 5’ TACGGCTACCTTGTTACGACTT 3’ 
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Fig. 2: Sequence of amplified of 16S rRNA (SF2 isolate) 
 
Based on the sequencing, the bacterial culture (MB) was identified 
as Bacillus amyloliquefaciens (Figure 1) and SF2 was identified as 
Bacillus licheniformis (Figure 2). The sequences were registered with 
NCBI GenBank (B. Amyloliquefaciens - KF186621.1; B. licheniformis - 
KF186622.1). Through NCBI Blast Analysis and Phylogenetic 
Dendrogram, it was confirmed that our isolates were indeed B. 
amyloliquefaciens and B. licheniformis (Figure 3 and Figure 4). 
 
 
Fig. 3: Phylogenetic Tree of B. amyloliquefaciens 
 
 
Fig. 4: Phylogenetic Tree of B. licheniformis 
 
Based on the primers: Fsp F: 5’ TCACAGCTTTTCTCGGTC ‘3; Fsp R: 
5’ TGATCCGATTACGAATGC ‘3, the Gene specific for Serine 
Protease (fibrinolytic enzyme) was amplified (Figure 5). 
 
 
Fig. 5: Amplification of fibrinolytic serine protease gene 
Lane 1: 1Kb Ladder (10,000 bp, 8000 bp, 6000 bp, 5000 bp, 4000 
bp, 3000 bp, 2500 bp, 2000 bp, 1500 bp, 1000 bp, 750 bp, 500 bp, 
250 bp 
Lane 2: PCR Amplicon of fibrinolytic serine protease gene (B. 
amyloliquefaciens) 
































Both B. amyloliquefaciens and B. licheniformis were grown in several 
media for the evaluation of their proteolytic enzyme production 
capability. Both the cultures produced maximal activities in 
Maltose+WheatBran medium; the proteolytic activity in B. 
.amyloliquefaciens was 15.85 U/mL (Figure 6) and in case of B. 
.licheniformis, the activity was 14.65 U/mL (Figure 7).  
 
 
Fig. 6: Proteolytic Activity of B. amyloliquefaciens in Different 
Media 
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When different carbon sources were tried at different dosages, the 
medium with maltose at 2.5% yielded higher activities; the activity 
was 18.21 U/mL in B. .amyloliquefaciens and 16.21 U/mL in B. 
.licheniformis. Similarly, when different nitrogen sources were used 
in the media in different dosages, ammonium nitrate at 0.3% gave 
maximal activity, 10.0 U/mL in B. .amyloliquefaciens; in case of B. 
.licheniformis, the activity was 8.76 U/mL.  
 
 
Fig. 7: Proteolytic activity of B. licheniformis in different media 
 
When the proteolytic activity was estimated in the medium with 
different dosages of Wheatbran, at 4% Wheatbran, B. 
.amyloliquefaciens produced 17.42 U/mL of enzyme, while B. 
.licheniformis produced an activity of 15.92 U/mL. The activity was 
maximal (16.28 U/mL) at 37 C in B. .amyloliquefaciens, whereas the 
activity was 15.78 U/mL in B. .licheniformis at 37 C. The proteolytic 
activity in B. .amyloliquefaciens was 15.52 U/mL in pH 7.0 and 15.38 
U/mL in pH 8.0. In case of B. .licheniformis the proteolytic activity 
was 14.86 U/mL at pH 7.0 and 15.01 U/mL at pH 8.0. The next batch 
of experiments was carried out to find out the exact pH of the media 
(7.0 – 8.0). At pH 7.2, the proteolytic activity was maximal at 15.56 
U/mL in B. .amyloliquefaciens. In case of B. .licheniformis, the activity 
was 15.13 U/mL at pH 7.4. 
 
 
Fig. 8: Proteolytic Activity of B. amyloliquefaciens 
 
 
Fig. 9: Proteolytic Activity of B. licheniformis 
In the optimized medium, Wheatbran at 4%, maltose at 2.5% and 
ammonium nitrate 0.3% (other components remaining the same), a 
maximal activity of 30.2 U/mL was obtained in B. .amyloliquefaciens 
at 72 h (Figure 8). In B. .licheniformis also the activity was maximal 
(28.12 U/mL) at 72 h (Figure 9). When the same culture filtrate was 
evaluated for fibrinolytic activity using Fibrin assay method, the activity 
was 28.98 FU/mL in B. .amyloliquefaciens and 26.63 FU/mL in B. 
.licheniformis (Table 2). The fibrinolytic activity of B. .amyloliquefaciens 
was 28.5 FU/mL and 28.21 FU/mL, when the agitation was adjusted to 
200 and 225 RPM, respectively. In case of B. .licheniformis the fibrinolytic 
activity was 27.2 FU/mL at 200 RPM. There was hardly any increase 
(27.28 FU/mL) when the agitation was increased to 225 RPM. Stability 
of the enzyme was evaluated at different pH (4.0 - 9.0) and temperature 
(35 C – 70 C) levels. The enzyme of B. .amyloliquefaciens was active at pH 
7.8 and temperature of 37 C. The enzyme was stable up to a temperature 
of 55 C. In B. .licheniformis, the enzyme was active at pH 8.0 and 
temperature 37 C and it was stable up to 50 C. 
 
Table 2: Fibrinolytic Activity 
Description State Activity 
(FU/mL)  
Nattokinase (Commercial) Powder 370 (FU/g)  
Fibrinolytic Enzyme B. 
.amyloliquefaciens 
Liquid 28.98  
Fibrinolytic Enzyme B. .licheniformis Liquid 26.63  
 
According to Al-Juamily et al [23], the optimal conditions for 
fibrinolytic enzyme production were determined, using a solid 
Lentils medium (activity 25.25 U/mL) at pH 7.2 (65.381 U/mL), 48 h 
incubation time (15.766 U/mL) and shaking incubator (95.992 
U/mL). The optimal carbon and nitrogen sources were mannitol and 
peptone or soya peptone with activity 44.0 and 50.0 unit/mL, 
respectively. Wang et al [3] reported that maltose was the best 
carbon and soy peptone was the best nitrogen sources for 
nattokinase production, however, Bhunia et al [24] inferred that 
lactose gave the maximal activity. In our study, it was observed that 
maltose and NH4NO3
In case of B. licheniformis, the fibrinolytic enzyme activity was 26.63 
FU/mL in the crude enzyme filtrate, 64.11 FU/mL in ammonium 
sulphate and 75.5 FU/mL after the Gel filteration (Table 4). The 
specific activity of 1.33 in the crude enzyme increased to 10.49 after 
ammonium sulphate precipitation and to 172.57 after the gel 
filtration. Simultaneously, the purity improved by 129.75 folds after 
passing through Sephadex gel. 
 were the best carbon and nitrogen sources for 
optimal enzyme production. In our study, we had experienced that 
the maximal activity was obtained at 200 rpm in shake flask studies. 
Kumar and Takagi [25] had tested different agitations (0, 50, 100 
and 200 RPM) for the maximal production of fibrinolytic enzyme 
and according to them, the optimum agitation speed was 200 RPM, 
which gave the maximal activity. The ability of the Bacillus 
licheniformis to produce fibrinolytic enzyme at different pH (6.2, 6.8, 
7.2, 7.5, 8) was studied [26]. According to Siraj [26], the productivity 
increased and the maximal activity was at the pH level of 7.2, which 
corresponds with our results. We obtained the maximal activity on 
72 h, whereas, Ellaiah and Srinivasulu [27] had mentioned that the 
optimum incubation period for serine protease activity was 24 h. 
However, Wang et al [3] mentioned that the maximal enzyme 
activity was achieved at 60 h. The studies on the optimum pH and 
temperature on the enzyme activity revealed that the enzyme was 
active at a pH level of 7.0 – 7.5 and at temperatures of 45 – 50 C. In a 
similar study, Babu et al [28] observed that the optimum pH for 
enzyme activity was 7.0 and the temperature was 37 C. 
The crude culture filtrate was purified partially with ammonium 
sulphate and Gel filtration methods. When the media components 
were optimized, the fibrinolytic enzyme activity of B. 
amyloliquefaciens in the culture filtrate was 28.98 FU/mL, which 
increased to 79.85 FU/mL in ammonium sulphate precipitate. After 
the Gel filtration the activity was 110.5 FU/mL. The specific activity 
increased from 1.38 in the crude enzyme to 11.41 in ammonium 
sulphate precipitate, to 210.47 after the gel filtration (Table 3). The 
purity of the enzyme improved by 152 folds after the gel filtration. 
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Table 3: Purification Table of B. .amyloliquefaciens 
Purification Step  Volume (mL) Total Protein (mg) Total Activity (U) Specific Activity 
(U/mg) 
Purification Fold 
Crude Extract  100 2100 2898 1.38 1.0 
(NH4)2SO4 20   140 1597 11.41 8.26 
Sephadex G-75  4 2.1 442 210.47 152.51 
 
Table 4: Purification Table of B.  icheniformis 
Purification Step  Volume (mL) Total Protein (mg) Total Activity (U) Specific Activity 
(U/mg) 
Purification Fold 
Crude Extract  100 2000 2663 1.33 1.0 
(NH4)2SO4 18   110 1154 10.49 7.88 
Sephadex G-75  4 1.75 302 172.57 129.75 
 
Scale up trials in a 7 L Laboratory fermentor were undertaken with 
B. amyloliquefaciens. In the first batch, the maximal activity was only 
24.9 FU/mL after 68 h. In the second batch, after some fine-tuning of 
the fermentor, an activity of 42.6 FU/mL was achieved. In the third 
batch, a new seed medium containing soybean meal was tried. 
However, the activity was only 35.0 FU/mL after 70 h. Therefore, the 
seed medium used for the first two batches was tried in the fourth 
batch with some modifications in the operating parameters of the 
fermentor. This batch, after 72 h, yielded an activity of 55.6 FU/mL 
(compared to that of 28.98 mg/mL in shake flask studies). The 
enzyme activity in the harvested broth after the filtration and 
centrifugation was 52.0 FU/mL. When concentrated through 
ultrafiltration, the activity increased to 210.0 FU/mL (Table 5). The 
concentrated enzyme was then made into a powder by Spray Drying 
methods and the fibrinolytic activity in the powder was 745.0 FU/g 
(Table 6). 
 
Table 5: Concentration of Enzyme 
Parameter  Volume (g)  Activity (FU/mL)  
Harvested Broth  1000  52.0  
Prefiltration (100µ)  1000  51.5  
Microfiltration (0.45µ)  985  50.25  
Ultrafiltration (10kDa)  200  210.0  
 
Table 6: Formulation of the Enzyme 
Parameter  Volume (g)  Activity 
Concentrated Enzyme  200  210.0 (FU/mL) 
Filler Materials:  
Dextrin 
Sodium chloride 





Spray dried powder  40  745.0 (FU/g) 
 
Table 7: Comparison of Enzymes based on Blood Clot Dissolution 
Fibrinolytic Enzyme  FU/mL  Blood clot dissolution time (min)  
Streptokinase  100  20  
t -PA  100  25  
Commercial Nattokinase  100  45  
Test Enzyme  100  35  
 
The Fibrinolytic activity of the test enzyme was higher than the other 
commercial protease / fibrinolytic enzymes. The time taken by the test 
enzyme for dissolving the blood clot was nearly the same as that of 
other available fibrinolytic enzymes (Table 7). As crystal structure of 
serine protease is unavailable, the 3-Dimensional structure (Figure 
10) was built using homology modeling tool of Schrodinger suite. The 
protein sequence of Nattokinase (Accession No. WP_017417394.1, 
length: 382 amino acid) was retrieved from NCBI GenBank [4]. The 
template protein was identified using BLASTp tool [5]: 
>tr|E5LCP0|E5LCP0_BACAM Fibrinolytic enzyme OS=Bacillus 














The crystallographic structure of 1SBN [29] was downloaded from 
Protein Data Bank (PDB) [30] and used as a template (resolution 
2.10 Å). The template and the target sequences showed 97% 
identity and 71% similarity with query coverage of 503 total score 
and E value of 7e-179. Thus, the sequence similarity between the 
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target and 1SBN is reasonable for selecting 1SBN as a suitable 
template for modeling of our sequence (Figure 11).  
 
 
Fig. 10: 3D structure of the modeled protein 
 
 
Fig. 11: Alignment between Template and Target Sequence 
 
The initial model was developed using Prime Module software [31]. 
The bumps were removed and missing side chain atoms were added 
using the WHAT IF Web Interface (http: //swift. .cmbi. .ru. 
.nl/servers/html/ index. .html). The prerefined model was examined 
through Ramachandran plot, among total 382 residues the phi-psi 
distribution for 293 residues (90.4%) constituting of core alpha (A), 
core beta (B) and core left-handed alpha were found in most 
favoured region [32]. The loop refinement was performed using 
Prime Module. The modeled structure was evaluated for its 
stereochemical quality using PROCHECK server [6]. The structural 
superimposition of 1SBN chain A and target protein was performed 
using PyMOL molecular viewer (http: //www. .pymol. .org) and the 
structural alignment was done using Genious Pro (http: //www. 
.geneious. .com/). Results obtained from the above analysis were 
used for defining the initial docking sites for protein and drug 
ligands for further docking and molecular simulation studies. 
The ligands were prepossessed using LigPrep tool of Schrodinger 
suite wherein the stereoisomer, tautomer, ionisation states were 
generated by Epik module [8]. The modeled protein was 
prepossessed using PrepWizard tool of Schrodinger suite which 
performs adding hydrogen, assigning bond-order, deleting 
heteroatoms and optimizing the protein. A grid for receptor centred 
at all residues was generated of 20, 20 and 20 Å (x, y and z) 
dimension. An extra precision, flexible ligand docking was 
performed using the generated grid. The in depth information of the 
binding site residue of the modeled protein and ligand residue was 
gained by visualising the docked protein-ligand binded complex 
structure at the atomistic basis. Based on the GlideScore obtained 
from post dock analysis, the highest interacting protein-ligand 
complex; protein-Curcumin Zn2+complex was subjected for 100 
picoseconds molecular dynamics simulation run employing 
MacroModel application of Schrodinger Suite. The atomic forces 
were defined by OPLS_2005 force field [33]. Trajectories were 
generated for 100 samples applying no constraints to bonds and 
angles. Simulation was performed in water solvent at 300K 
temperature using PRCG minimisation method for 500 iterations 
and 0.05 convergence threshold. The root mean squared deviation 
(RMSD) of the atomic position of the modeled protein-ligand 
complex with time was observed to understand whether the binding 
of ligand with the protein causes any structural deformation of the 
modeled serine protease protein. The superimposed configuration 
of all 100 samples at each picosecond is shown in Figure 12 and the 
RMSD plot of the protein-Curcumin Zn2+complex for 100 
picoseconds simulation run confirmed the stability of the protein 
structure. 
 
Fig. 12: Superimposed Configuration of Modeled Serine 
Protease-Curcumin Zn2+
 
Complex for 100 Ps MD Simulation Run 
Vasantha et al [34] had designed the Forward (5_-ATGGCGCAGTCCG 
TGCCTTAC-3_) and reverse (5_-TTACTG-AGCTGCCGCCTGTAC-3_) 
primers from the nucleotide sequence corresponding to the 
Nattokinase peptide, in order to amplify the sequence. Sequencing of 
the amplified fragment revealed 100% similarity between the 
peptides of the fibrinolytic (Nattokinase) from B. amyloliquefaciens 
and the published literature. Homology among these and other 
bacterial serine proteases was checked using the BLAST algorithm 
(NCBI, http: //www. .ncbi. .nlm. .nih. .gov). B. subtilis K-54, which 
originates from traditional Korean food, produces the fibrinolytic 
enzyme subtilisin K-54. The fibrinolytic (Nattokinase) enzyme 
produced by our strain, B. amyloliquefaciens isolated from spoilt 
milk, and subtilisin K-54 displayed the highest similarity and may 
therefore have a very similar three-dimensional structure, especially 
around the substrate binding sites. The crystal structure is 
unavailable for serine protease so the similarity observed between 
1SBN and serine protease showed that 1SBN can be used as 
template sequence for 3-Dimensional structure modeling of target 
protein. Ligands were retrieved from PubChem compound database 
and their pharmacodynamics and pharmacokinetics properties were 
studied. The selected ligands were interacted with the modeled 
protein sequence. The detailed various energy contribution to the 
glide scoring function combined by Emodel score shows that the 
GlideScore for protein-Curcumin Zn2+ complex possess highest 
interaction energy of -5.49 kcal/mol as compared to other drug 
ligands. The ChemScore of lipophilic pair term and the fraction of 
the total protein-ligand van der Waals energy were found to have -
3.72 kcal/mol of contribution and was dominant as compared to 
other interaction energy factors like hydrogen bond ChemScore (-
1.83 kcal/mol) electrostatic rewards (-0.52 kcal/mol) and penalty 
for low molecular weight (-0.27 kcal/mol). This can be attributed to 
the involvement of lipophilic or hydrophobic protein residue leucine 
(LEU 82) in binding of Curcumin with the serine protease moreover 
the minimal electrostatic reward is due to polar but uncharged 
asparagine (ASN 77) residue interaction with the ligand. The 
hydrogen bonding interaction (Figure 13 and Figure 14) of leucine 
O-atom and asparagine H-atom with Curcumin Zn2+ at bond distance 
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of 2.136 Å and 2.053 Å respectively (Table 4.8) and leucine being 
one of the oxidatively stable residue provides stability to the 
protein-ligand complex. This essentially indicates that the 
nonbonded force of -3.72 kcal/mol makes Curcumin 
conformationally fit to the binding site via non-bonded interaction. 
Tailoring of protein residues may enhance stability and binding 
affinity of protein-Curcumin Zn2+
 
 complex. A 100 ps molecular 
dynamics simulation run further strengthened the view that the 
molecular interaction maintains the stability of protein and 
curcumin after binding to protein does not deform or vary the 
protein conformation. The root means squared deviation analysis 
clearly implies that the protein-ligand complex is quite stable. 
 
Fig. 13: Interaction profile of docked protein-inhibitor ligand complex binding site (hydrogen bond is shown by red dotted) 
 
Protein-ligand binding affinity being one of the major keys for 
understanding therapeutic application of a drug was studied of 
modeled serine protease and selective ligands. The molecular 
docking study implied serine protease and Curcumin Zn2+
 
 complex 
possesses highest interaction profile with GlideScore of -5.49 
kcal/mol.
 
Fig. 14: Interaction profile of docked protein-activator ligand complex binding site and docked protein-activator and inhibitor (zn2+
 
) 
complex b (hydrogen bond is shown by red dotted line) 
The protein residues, leucine and asparagine, were the active site of 
interaction of Curcumin Zn2+
Molecular dynamics simulation of modeled serine protease and 
Curcumin Zn
 complex with the protein.  
2+complex for 100 ps showed protein-ligand complex 
stability during simulation and at 100th
CONCLUSION 
 ps simulation run.  
In this research work, two species of Bacillus, namely, Bacillus 
amyloliquefaciens and Bacillus licheniformis, were isolated from 
spoilt milk and soy flour, respectively, which exhibited fibrinolytic 
(Nattokinase) activity. In the laboratory scale studies, of these two 
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cultures, B. amyloliquefaciens produced the Fibrinolytic enzyme in 
higher quantities, 28.98 FU/mL, compared to 26.63 FU/mL in B. 
licheniformis. The maximal activities were obtained after 72 h. The 
optimum conditions at laboratory for maximal production of the 
fibrinolytic (Nattokinase) enzyme were: pH 7.2, temperature 37 C 
and agitation 200 rpm. When scale up studies with B. 
amyloliquefaciens in a laboratory 7 L Fermentor were undertaken, 
the maximal activity obtained was 55.6 FU/mL in 72 h, compared to 
that of 28.98 FU/mL in shake flask studies. The increase in activity in 
the Fermentor by about 2 times more than the shake flasks clearly 
indicates that the activity of 55.6 FU/mL is positively expected to 
increase to about 100.0 FU/mL in the large fermentors during 
commercial operation. After ultrafiltration, the activity improved to 
210 FU/mL and in the spray dried powder, the activity as 745 FU/g. 
The molecular weight of the enzyme was estimated to be about 38 
kDa. The enzyme had exhibited excellent blood clot dissolving 
property and therefore may be considered for further scale up and 
commercial exploitation. 
An in-silico study has been performed to investigate the activators 
and inhibitors of serine protease. A 3-D structure of serine protease 
has been modeled by homology modeling. Binding affinity between 
protein and ligand plays a major role in enhancing or inhibiting the 
biological activity of a protein which can be understood by 
molecular docking studies. In in-silico studies, it was observed that 
PMSF acts as an inhibitor, thereby, confirming this fibrinolytic 
enzyme is a serine protease (Nattokinase). The future prospects of 
this study are to scale up the production trials in fermentors of 50 L 
and above capacities. The downstream processing has to be 
standardized in order to reduce the loss in activity and to formulate 
the enzyme as a powder for commercial exploitation as a 
Nutraceutical.  
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